Skip to main content Skip to navigation

Diabetes Prevention in Pharmacies

Community Pharmacy Foundation
6/1/2013 – 10/30/2014


Diabetes affects over 2.58 million citizens – 8.3% of the population – in the United States. An estimated 79 million citizens over the age of 20 have pre-diabetes. Diabetes is the leading cause of kidney failure, non-traumatic lower-limb amputation and new onset blindness in American adults. It is a major cause of heart disease and stroke and is the seventh leading cause of death in the United States. Estimated diabetes-related costs nationwide exceeded $170 billion in 2007. A health care crisis exists related to the personal and societal costs of diabetes. The Diabetes Prevention Program and the modified Group Lifestyle Balance program are lifestyle interventions proven to prevent or delay progression of pre-diabetes to diabetes. In this project, we aim to develop and evaluate the delivery of the Group Lifestyle Balance program in community pharmacies using trained student pharmacists and nutrition and exercise physiologist students. Pharmacists are highly accessible and effective healthcare professionals to people in communities across America. Preparing them to deliver a proven diabetes prevention program in their readily accessible pharmacies leverages great potential for reaching citizens and impacting the diabetes epidemic in the United States. The pharmacy implementation will work in tandem with the reimbursement model development to document the successful role of the pharmacist to deliver diabetes prevention education.

Primary Investigator

Lisa Woodard, PharmD, MPH
WSU College of Pharmacy